Lust4Me [OP] 1 points 6y ago
*After* the discoveries, of course everyone is investing in this revolutionary technology. Commercialization of novel applications is one thing, but restricting future companies from exploring the natural method evolved by bacteria through natural selection?
The patents are being pursed by the universities, which would restrict the very companies you're quoting above.
The very article YOU quote states:
> It’s a big leap for a technology that has yet to even be tried in patients – **especially since the intellectual property landscape around CRISPR-Cas9 is treacherous. Jennifer Doudna and Emmanuel Charpentier published the first paper detailing how to use the enzyme to cut DNA. They filed for a patent for using it to edit the DNA of cells with nuclei – like those of plants, animals, and people – too. But Feng Zhang of the Broad Institute filed a separate patent on using it in cells with nuclei, and it was granted first.**